Page last updated: 2024-10-24

cefuroxime and Constriction, Pathological

cefuroxime has been researched along with Constriction, Pathological in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weintraub, A1
Mankuta, D1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Paracetamol (Acetaminophen) for Closure of PDA in Preterm Infants[NCT01755728]Phase 319 participants (Actual)Interventional2013-01-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for cefuroxime and Constriction, Pathological

ArticleYear
Dipyrone-induced oligohydramnios and ductus arteriosus restriction.
    The Israel Medical Association journal : IMAJ, 2006, Volume: 8, Issue:10

    Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non

2006